13 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 13 of 13 clinical reviews.
A complete caregiver guide to administering sermorelin acetate to adolescents aged 12 to 17, covering dosing, injection technique, storage, monitoring, and safety considerations prepared by the HealthRX.com Editorial Team.
A guide covering how sermorelin acetate affects sleep, focus, athletic performance, and daily scheduling for adolescents aged 12 to 17, with dosing context, safety data, and practical school-day protocols.
A guide to sermorelin use in adults 65+ covering physical activity planning, cognitive engagement, safety monitoring, and dose adjustments specific to the geriatric patient.
A comprehensive clinical guide to sermorelin use in patients 65 and older, covering dose adjustments, safety monitoring, evidence from key trials, and how to transition from adult to geriatric protocols.
Step-by-step caregiver guidance for administering sermorelin acetate to adults aged 65 and older, including injection technique, dose titration, safety monitoring, and when to call the prescriber.
A look at how sermorelin acetate affects puberty, growth-plate status, IGF-1 levels, body composition, and long-term development in adolescents ages 12 to 17, with primary-source citations throughout.
A clinical guide to transitioning adolescent patients (ages 12 to 17) from sermorelin therapy to adult growth hormone protocols, covering timing, dosing shifts, monitoring benchmarks, and guideline-based decision points.
A clinical review of sermorelin acetate use in adolescents ages 12 to 17, covering FDA approval status, off-label rationale, dosing, safety signals, and when a specialist referral is required.
A guide to sermorelin acetate's developmental impact in geriatric patients aged 65 and older, covering GH axis physiology, clinical evidence, dosing, safety, and practical prescribing guidance.
A clinical deep-dive into off-label sermorelin use in geriatric patients (65+), covering the evidence base, dosing considerations, safety signals, and what prescribers should know before initiating therapy.
A guide to sermorelin's developmental effects in pediatric patients under age 12, covering growth outcomes, GH axis physiology, dosing, safety data, and FDA regulatory status.
A clinical guide to transitioning pediatric patients under age 12 from sermorelin therapy to adult-focused growth hormone management, including evidence-based protocols, dosing shifts, and monitoring benchmarks.
A clinical guide for parents and prescribers on how sermorelin therapy affects school performance, physical activity, sleep, and daily scheduling in children under age 12.